[HTML] cell.comFull View

[HTML][HTML] Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - cell.com
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …
被引用次数：139 相关文章

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - infona.pl
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - 2015 - dspace.mit.edu
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …

Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope.

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - 2015 - cabidigitallibrary.org
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …

[引用][C] Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - cir.nii.ac.jp
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant
Epitope | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML] cell.com

[HTML][HTML] Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - cell.com
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …
[PDF] core.ac.uk

[PDF][PDF] Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - core.ac.uk
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - europepmc.org
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …
[HTML] nih.gov

[HTML][HTML] Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley, VV Costa… - Cell, 2015 - ncbi.nlm.nih.gov
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

LN Robinson, K Tharakaraman, KJ Rowley… - Cell, 2015 - pubmed.ncbi.nlm.nih.gov
Dengue is the most common vector-borne viral disease, causing nearly 400 million
infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit …